CELZ — Creative Medical Technology Holdings Share News
0.000.00%
Last trade - 00:00- $4.88m
- -$3.81m
- $0.01m
Creative Medical Technology Holdings Inc expected to post a loss of 52 cents a share - Earnings Preview
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Meta Platforms, Dexcom, Dell
U.S. STOCKS ON THE MOVE- Analog Devices, GameStop, Moderna
Creative Medical Technology rises on positive data for stem cell therapy
Brief: Creative Medical Technology Holdings, Inc. Advances FDA Cleared Adapt Clinical Trial With Positive Independent Review, Validating The Safety And Potential Of CELZ-201 For Chronic Lower Back Pain Treatment
Creative Medical Technology Holdings Inc expected to post a loss of 87 cents a share - Earnings Preview
Brief: Creative Medical Technology Holdings Inc Files For Mixed Shelf Of Up To $50 Million - SEC Filing
Creative Medical Technology Holdings Inc reports results for the quarter ended in June - Earnings Summary
Creative Medical Technology Holdings Inc expected to post a loss of 84 cents a share - Earnings Preview
Brief: Creative Medical Successfully Generated Human Ipsc-Derived Islet Cells That Produce Human Insulin
Creative Medical Technology Holdings Inc expected to post a loss of $1.16 a share - Earnings Preview
Creative Medical Technology Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Creative Medical Technology Provides Corporate Update
Creative Medical Technology Holdings Inc reports results for the quarter ended in December - Earnings Summary
Creative Medical Technology Holdings Inc expected to post a loss of $1.13 a share - Earnings Preview
Brief: Creative Medical Announces US FDA Authorization For Type 1 Diabetes Prevention Therapy Under Expanded Access
U.S. STOCKS ON THE MOVE-Silver miners, Albemarle, Pfizer